Almost certainly not CF33 being used on that patient nor any other IMU drug. I'm pretty sure HER-Vaxx is the only IMU drug being trialled at Queen Elizabeth Hospital in Adelaide, and the trial is only open to gastric cancers. Also, worth bearing in mind it appears he has stable disease while the expectation for CF33 is that it will obliterate cancer and not "simply" stop it from growing any further.
Here's the link to the clinical trials webpage for the VAXINIA MAST study, which includes the trial sites:
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
Media Thread, page-8955
-
- There are more pages in this discussion • 5,710 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |